Expectations
- Organism
- Homo sapiens
- Assay
- bulk RNA-seq
- Specimen/source
- patient tissue or biopsy
- Controls
- matched normal, adjacent normal, paired normal, healthy tissue control, or otherwise normal tissue control
Siftome Phase 3L
GSE22260Both case and control groups are present in the proposed grouping.
Each contrast group has at least 2 samples.
Processed data is marked available in the GEO index.
All samples are assigned to a case or control group.
No dataset warnings are present.
Metadata quality is high enough to support downstream handoff.
No readiness blockers detected.
Siftome proposed case and control labels, but no reviewer confirmation is stored yet.
Open the sample grouping CSV and confirm group labels before analysis.Both groups meet the minimum of 2 samples.
Confirm whether the cohort is large enough for the intended statistical analysis.Processed data availability is marked true in the GEO index.
Verify that downloaded processed files contain usable count or expression identifiers.No review-needed or unassigned samples are present in the proposed grouping.
Still scan the grouping table for biology-specific ambiguity.No hard-excluded samples were detected by the current rules.
Record any manual exclusions in the downstream analysis notes.The dataset and sample accessions can be linked back to GEO.
Keep GEO dataset and sample links with exported metadata.Proceed only after the analyst confirms grouping, exclusions, and source files.
No expert-review triggers were detected by Siftome.
No ranking warnings are active.
No active review decisions affect this ranking.
No active manual corrections are applied to this dataset.
Homo sapiens
dataset_accession: GSE22260 organism: Homo sapiens dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq
bulk RNA-seq
assay_type: bulk RNA-seq experiment_types: Expression profiling by high throughput sequencing platforms: GPL9115 Illumina Genome Analyzer II (Homo sapiens) dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq
Tumor vs matched normal
dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq experiment_types: Expression profiling by high throughput sequencing sample_context: GSM554076: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554078: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554080: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing GSM554082: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequenci [Correction source preview truncated.]
Tissue
dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq sample_context: GSM554076: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554078: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554080: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing GSM554082: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554084: source_name=Prostate adenocarcinoma; characteristics=ti [Correction source preview truncated.]
prostate cancer
dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq sample_context: GSM554076: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554078: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554080: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing GSM554082: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554084: source_name=Prostate adenocarcinoma; characteristics=ti [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE22260 dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM554076: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554078: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554080: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing GSM554082: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer s [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE22260 dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM554076: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554078: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing GSM554080: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing GSM554082: source_name=Prostate adenocarcinoma; characteristics=tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer s [Correction source preview truncated.]
tumor sample (case)
sample_accession: GSM554076 sample_title: carcinoma_C02 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554076 sample_title: carcinoma_C02 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554078 sample_title: carcinoma_C03 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554078 sample_title: carcinoma_C03 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554080 sample_title: carcinoma_C05 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554080 sample_title: carcinoma_C05 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554082 sample_title: carcinoma_C06 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554082 sample_title: carcinoma_C06 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554084 sample_title: carcinoma_C07 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554084 sample_title: carcinoma_C07 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554086 sample_title: carcinoma_C08 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554086 sample_title: carcinoma_C08 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554088 sample_title: carcinoma_C09 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554088 sample_title: carcinoma_C09 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554090 sample_title: carcinoma_C11 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554090 sample_title: carcinoma_C11 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554092 sample_title: carcinoma_C13 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554092 sample_title: carcinoma_C13 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554094 sample_title: carcinoma_C15 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554094 sample_title: carcinoma_C15 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554096 sample_title: carcinoma_C16 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554096 sample_title: carcinoma_C16 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554098 sample_title: carcinoma_C18 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554098 sample_title: carcinoma_C18 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554100 sample_title: carcinoma_C19 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 9; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554100 sample_title: carcinoma_C19 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 9; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554102 sample_title: carcinoma_C23 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 8; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554102 sample_title: carcinoma_C23 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 8; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554104 sample_title: carcinoma_C27 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554104 sample_title: carcinoma_C27 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554106 sample_title: carcinoma_C29 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554106 sample_title: carcinoma_C29 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554108 sample_title: carcinoma_C33 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554108 sample_title: carcinoma_C33 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554110 sample_title: carcinoma_C37 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554110 sample_title: carcinoma_C37 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554112 sample_title: carcinoma_C39 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554112 sample_title: carcinoma_C39 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 7; sequencing protocol: paired-end, 36-mer sequencing
tumor sample (case)
sample_accession: GSM554114 sample_title: carcinoma_C40 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as tumor sample
sample_accession: GSM554114 sample_title: carcinoma_C40 source_name: Prostate adenocarcinoma characteristics: tissue: Prostate cancer tissue; tumor stage: Gleason score 6; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554116 sample_title: normal_N02 source_name: Prostate matched normal of C02 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554116 sample_title: normal_N02 source_name: Prostate matched normal of C02 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554118 sample_title: normal_N03 source_name: Prostate matched normal of C03 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554118 sample_title: normal_N03 source_name: Prostate matched normal of C03 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554120 sample_title: normal_N06 source_name: Prostate matched normal of C06 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554120 sample_title: normal_N06 source_name: Prostate matched normal of C06 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554122 sample_title: normal_N08 source_name: Prostate matched normal of C08 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554122 sample_title: normal_N08 source_name: Prostate matched normal of C08 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554124 sample_title: normal_N09 source_name: Prostate matched normal of C09 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554124 sample_title: normal_N09 source_name: Prostate matched normal of C09 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554126 sample_title: normal_N11 source_name: Prostate matched normal of C11 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554126 sample_title: normal_N11 source_name: Prostate matched normal of C11 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554128 sample_title: normal_N13 source_name: Prostate matched normal of C13 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554128 sample_title: normal_N13 source_name: Prostate matched normal of C13 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554130 sample_title: normal_N15 source_name: Prostate matched normal of C15 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554130 sample_title: normal_N15 source_name: Prostate matched normal of C15 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554132 sample_title: normal_N19 source_name: Prostate matched normal of C19 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554132 sample_title: normal_N19 source_name: Prostate matched normal of C19 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
normal tissue (control)
sample_accession: GSM554134 sample_title: normal_N23 source_name: Prostate matched normal of C23 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Included in derived sample grouping as normal tissue
sample_accession: GSM554134 sample_title: normal_N23 source_name: Prostate matched normal of C23 characteristics: tissue: Normal prostate tissue; tumor stage: NA; sequencing protocol: paired-end, 36-mer sequencing
Original dataset metadata, sample metadata, source links, and GEO data availability flags.
Planned trusted source for processed count availability.
Planned source for curated expression experiment links.
Publication context when PubMed identifiers are already known.
No project feedback stored for this dataset.
dataset_accession: GSE22260 dataset_title: Comparative transcriptomic analysis of prostate cancer and matched normal tissue using RNA-seq organism: Homo sapiens assay_type: bulk RNA-seq processed_data_available: true raw_data_available: true submission_date: 2010-06-09 last_update_date: 2019-05-15 organization_name: Mayo Clinic department: Division of Computational Biology public_date: 2011-05-02 experiment_types: Expression profiling by high throughput sequencing platforms: GPL9115 Illumina Genome Analyzer II (Homo sapiens) sub_series: Not available bioproject: PRJNA128733 supplementary_files: TAR: GSE22260_RAW.tar series_type: Series
No warnings
Samples currently treated as the comparison case group.
Samples currently treated as controls or baseline.
Samples with no explicit case or control marker.
No samples
Samples excluded from grouping by hard exclusion rules.
No samples
Samples that need manual review before trusting grouping.
No samples
No review decisions have been stored for this dataset.